BAY 11-7082
别名: BAY 11-7821
目录号:S2913 Purity: 99.98%
BAY 11-7082 (BAY 11-7821)是一种 NF-κB 抑制剂,抑制TNFα诱导的 IκBα 磷酸化,在肿瘤细胞中IC50为10 μM。BAY 11-7082 可抑制 ubiquitin-specific protease USP7 和 USP21,对应的IC50值分别为0.19 μM和0.96 μM。BAY 11-7082 在胃癌细胞中可诱导凋亡和S期阻滞。
CAS: 19542-67-7
客户使用Selleck的BAY 11-7082发表文献370篇
- Nat Cancer, 2024 10.1038/s43018-023-00712-x
- Nat Med, 2022 28(4):752-765
- Gastroenterology, 2022 162(6):1716-1731.e17
- Signal Transduct Target Ther, 2021 6(1):333
- Nat Cell Biol, 2021 23(4):355-365
- Cell Mol Immunol, 2019 10.1038/s41423-019-0281-6
- Blood, 2019 134(13):1084-1094
- Immunity, 2018 49(6):1049-1061
- Cell Mol Immunol, 2017 14(10):830-841
- Cell Mol Immunol, 2017 14(3):265-275
- Nat Cell Biol, 2017 19(10):1274-1285
- Science, 2016 354(6315)
- Gastroenterology, 2015 149(4):981-92.e11
- Exp Mol Med, 2024 56(12):2602-2616
- Redox Biol, 2024 76:103323
- Redox Biol, 2024 70:103072
- J Nanobiotechnology, 2024 22(1):362
- Int J Biol Sci, 2024 20(12):4941-4956
- Int J Biol Sci, 2024 20(14):5695-5714
- Int J Biol Sci, 2024 20(6):2323-2338
- Cell Death Dis, 2024 15(1):70
- Cell Rep, 2024 43(2):113780
- Cell Rep, 2024 43(3):113963
- Oncogene, 2024 10.1038/s41388-024-03068-3
- EMBO Rep, 2024 10.1038/s44319-024-00324-1
- J Transl Med, 2024 22(1):975
- Front Immunol, 2024 15:1388947
- Cell Mol Gastroenterol Hepatol, 2024 17(6):939-964
- Cell Death Discov, 2024 10(1):9
- Commun Biol, 2024 7(1):488
- J Biol Chem, 2024 S0021-9258(24)02253-1
- Neoplasia, 2024 58:101065
- J Biol Chem, 2024 300(1):105566
- Sci Rep, 2024 14(1):5078
- Mol Cell Oncol, 2024 11(1):2423986
- Cell Death Dis, 2023 14(7):481
- Cell Rep, 2023 42(1):112005
- Cell Rep, 2023 42(6):112647
- Cell Rep, 2023 42(7):112804
- Front Immunol, 2023 14:1192861
- Commun Biol, 2023 10.1038/s42003-023-05395-9
- Int J Mol Sci, 2023 24(7)6322
- J Biol Chem, 2023 299(1):102787
- Biomedicines, 2023 11(8)2221
- Immunol Lett, 2023 255:54-61
- Reprod Biol Endocrinol, 2023 21(1):50
- Drug Des Devel Ther, 2023 17:2821-2839
- World J Stem Cells, 2023 15(8):787-806
- Front Physiol, 2023 14:1249662
- Cytokine, 2023 169:156302
- PLoS One, 2023 18(8):e0289071
- Front Vet Sci, 2023 10:1203012
- Am J Transl Res, 2023
- Clin Respir J, 2023 17(3):241-250
- THE UNIVERSITY OF ARIZONA, 2023
- Nat Commun, 2022 13(1):3117
- Nat Commun, 2022 13(1):5494
- Adv Sci (Weinh), 2022 10.1002/advs.202104055
- Mol Ther, 2022 S1525-0016-2200552-4
- Theranostics, 2022 12(9):4386-4398
- J Exp Clin Cancer Res, 2022 41(1):174
- MedComm (2020), 2022 3(2):e132
- Cancer Lett, 2022 532:215598
- JCI Insight, 2022 7(3)e145475
- Oncogene, 2022 10.1038/s41388-022-02540-2
- Cell Mol Life Sci, 2022 79(3):155
- Elife, 2022 11e74782
- Cell Biosci, 2022 12(1):193
- Front Immunol, 2022 13:921613
- Front Immunol, 2022 13:734171
- Front Immunol, 2022 13:984520
- Cells, 2022 11(10)1630
- Nutrients, 2022 14(18)3721
- Nutrients, 2022 14(20)4257
- Commun Chem, 2022 5(1):61
- iScience, 2022 25(10):105182
- J Nutr Biochem, 2022 S0955-2863(22)00134-6
- Front Pharmacol, 2022 13:974216
- J Leukoc Biol, 2022 10.1002/JLB.3MA0322-171R
- J Leukoc Biol, 2022 111(5):1107-1121
- J Ethnopharmacol, 2022 301:115833
- Mar Drugs, 2022 20(9)575
- J Cell Mol Med, 2022 6(10):2819-2830
- Cancers (Basel), 2022 14(3)531
- Virulence, 2022 13(1):1486-1501
- Virulence, 2022 13(1):1407-1422
- Virol J, 2022 19(1):119
- Virol J, 2022 19(1):110
- Ann Transl Med, 2022 10(22):1203
- Molecules, 2022 27(22)8059
- J Immunol Res, 2022 2022:4727198
- Biosci Rep, 2022 42(3)BSR20212224
- Oral Dis, 2022 10.1111/odi.14294
- Biomed Res Int, 2022 2022:9230784
- Biomed Res Int, 2022 2022:9453270
- J Cancer Res Clin Oncol, 2022 1007/s00432-022-04197-6
- J Dairy Sci, 2022 105-10:8426-8438
- Genes (Basel), 2022 13(11)2133
- Chin J Integr Med, 2022 10.1007/s11655-022-3464-4
- Pathol Oncol Res, 2022 28:1610273
- Cardiovasc Diagn Ther, 2022 12(2):196-207
- Front Oral Health, 2022 3:867793
- Nat Commun, 2021 12(1):1394
- Autophagy, 2021 1-19
- Mol Ther, 2021 S1525-0016(21)00019-8
- J Exp Clin Cancer Res, 2021 40(1):301
- Clin Transl Med, 2021 11(6):e448
- J Neuroinflammation, 2021 18(1):182
- J Neuroinflammation, 2021 18(1):261
- Int J Biol Sci, 2021 17(11):2683-2702
- Cell Death Dis, 2021 12(2):172
- Cell Rep, 2021 34(1):108584
- Food Chem, 2021 348:129111
- Int J Biol Macromol, 2021 180:129-142
- Oncogene, 2021 10.1038/s41388-021-01900-8
- EMBO Rep, 2021 22(9):e52576
- Front Immunol, 2021 12:661939
- Oxid Med Cell Longev, 2021 2021:2915019
- Front Immunol, 2021 12:657071
- Front Immunol, 2021 12:779667
- Immunology, 2021 163(2):201-219
- Life Sci, 2021 274:119324
- Front Pharmacol, 2021 12:670586
- Clin Transl Immunology, 2021 10(6):e1300
- Cancer Cell Int, 2021 21(1):191
- Front Pharmacol, 2021 12:592184
- Int J Mol Sci, 2021 22(16)8648
- Front Pharmacol, 2021 12:641848
- Front Pharmacol, 2021 12:627557
- J Cell Physiol, 2021 236(2):1375-1390
- Int Immunopharmacol, 2021 103:108456
- Front Cell Dev Biol, 2021 9:647713
- Respir Res, 2021 22(1):193
- Virulence, 2021 12(1):2352-2365
- Aging (Albany NY), 2021 13(6):8078-8094
- Front Psychiatry, 2021 12:644383
- Front Oncol, 2021 11:728047
- J Periodontol, 2021 10.1002/JPER.21-0290
- ACS Omega, 2021 6(42):27791-27797
- J Cell Sci, 2021 134(24)jcs259306
- Microb Pathog, 2021 S0882-4010(21)00493-9
- Pharm Biol, 2021 59(1):760-768
- Am J Reprod Immunol, 2021 10.1111/aji.13403
- Parasit Vectors, 2021 14(1):358
- Dev Comp Immunol, 2021 127:104292
- Dev Comp Immunol, 2021 128:104327
- Dev Comp Immunol, 2021 125:104208
- Exp Physiol, 2021 10.1113/EP089887
- Exp Ther Med, 2021 22(6):1391
- Exp Ther Med, 2021 22(6):1436
- Mamm Genome, 2021 10.1007/s00335-021-09883-3
- Am J Transl Res, 2021 13(2):708-718
- Research Square, 2021 10.21203/rs.3.rs-611538/v1
- Nat Commun, 2020 19;11(1):2487
- Hepatology, 2020 10.1002
- Autophagy, 2020 1-20
- Cell Death Differ, 2020 7
- Cell Death Differ, 2020 10.1038/s41418-020-0591-3
- Gut Microbes, 2020 11(3):511-525
- Redox Biol, 2020 28:101319
- J Immunother Cancer, 2020 8(2)e000807
- J Immunother Cancer, 2020 8(2)e000517
- J Neuroinflammation, 2020 17(1):364
- Cell Death Dis, 2020 17;11(4):239
- Cell Rep, 2020 5;31(5):107585
- Elife, 2020 30;9. pii: e51317
- Thromb Res, 2020 5;190:26-34
- Oxid Med Cell Longev, 2020 2020:7028947
- Cell Death Discov, 2020 4;6:33
- Cell Death Discov, 2020 20;6:24
- Life Sci, 2020 265:118832
- Cells, 2020 13;9(5) pii: E1209
- Cancer Cell Int, 2020 20:483
- Front Pharmacol, 2020 11:575390
- J Cell Physiol, 2020 235(4):3519-3528
- Eur J Immunol, 2020 10.1002/eji.201948363
- Eur J Immunol, 2020 27
- Mol Cancer Res, 2020 10.1158/1541-7786.MCR-19-0669
- Inflammation, 2020 43(2):455-465
- Inflammation, 2020 10.1007
- Eur J Pharmacol, 2020 873:172981
- Eur J Pharmacol, 2020 868:172886
- J Biol Chem, 2020 295(8):2186-2202
- FASEB J, 2020 10.1096/fj.202000080RR
- Viruses, 2020 12(9)E1021
- Mol Carcinog, 2020 59(2):154-167
- Sci Rep, 2020 10(1):882
- Food Chem Toxicol, 2020 139:111274
- Transbound Emerg Dis, 2020 67(4):1492-1506
- Analyst, 2020 21;145(10):3535-3542
- Oral Dis, 2020 10.1111
- Exp Mol Pathol, 2020 112:104328
- Cancer Manag Res, 2020 12:8413-8424
- J Neurovirol, 2020 26(1):84-94
- Dev Comp Immunol, 2020 105:103588
- Exp Ther Med, 2020 20(5):116
- Exp Ther Med, 2020 19(2):871-882
- Histochem Cell Biol, 2020 10.1007/s00418-020-01923-4
- J Radiat Res, 2020 22;61(3):352-367
- Sci Adv, 2020 26;6(9):eaay9269
- Adv Wound Care (New Rochelle), 2020 1;9(5):219-232
- Brain Behav Immun Health, 2020 2100030
- Nat Commun, 2019 10(1):2924
- Mol Cell, 2019 76(1):148-162
- Biomaterials, 2019 192:523-536
- J Autoimmun, 2019 102:96-113
- Redox Biol, 2019 22:101137
- Carbohydr Polym, 2019 206:706-715
- Carbohydr Polym, 2019 214:34-43
- EBioMedicine, 2019
- J Immunother Cancer, 2019 7(1):346
- Cancer Lett, 2019 447:93-104
- Cell Death Dis, 2019 10(11):819
- Cell Death Dis, 2019 10(4):319
- Cell Rep, 2019 26(6):1544-1556
- Cell Prolif, 2019 52(5):e12664
- Int J Biol Macromol, 2019 136:980-993
- Int J Biol Macromol, 2019 135:212-225
- Phytomedicine, 2019 67:153163
- Biomed Pharmacother, 2019 112:108714
- Stem Cell Res Ther, 2019 10(1):213
- Free Radic Biol Med, 2019 137:24-36
- J Pathol, 2019 247(4):481-493
- Front Immunol, 2019 10:524
- J Lipid Res, 2019 60(6):1078-1086
- Cancer Sci, 2019
- Mol Cancer Ther, 2019 10.1158/1535-7163.MCT-18-1215
- Int Immunopharmacol, 2019 66:224-235
- Int Immunopharmacol, 2019 69:270-278
- J Cell Physiol, 2019 234(10):18017-18028
- J Cell Mol Med, 2019 23(8):5303-5316
- J Cell Mol Med, 2019 23(4):2689-2701
- Front Microbiol, 2019
- Front Microbiol, 2019 10:2962
- Eur J Pharmacol, 2019 851:122-132
- Eur J Pharmacol, 2019 857:172449
- Eur J Pharmacol, 2019 865:172760
- Drug Des Devel Ther, 2019 13:975-990
- Front Mol Neurosci, 2019 12:210
- Neoplasia, 2019 21(2):206-215
- FASEB J, 2019 33(5):6551-6563
- J Biol Chem, 2019 294(35):12866-12879
- Viruses, 2019 11(11)E1021
- Molecules, 2019 24(6)
- Mediators Inflamm, 2019
- J Diabetes Res, 2019 2019:8151836
- J Cell Sci, 2019 132(15)jcs228213
- Immunol Cell Biol, 2019 97(4):403-415
- Xenotransplantation, 2019 26(6):e12536
- Toxicol Appl Pharmacol, 2019 370:44-55
- Gene, 2019 710:91-97
- Mol Med Rep, 2019 20(4):3487-3498
- Biochem Biophys Res Commun, 2019 518(1):59-65
- Arch Oral Biol, 2019 103:33-39
- J Anesth, 2019 33(6):685-693
- Exp Ther Med, 2019 18(3):1587-1594
- J Toxicol Environ Health A, 2019 82(3):157-162
- Dev Growth Differ, 2019 61(7-8):410-418
- Microsc Res Tech, 2019 82(12):2000-2006
- Vet Comp Oncol, 2019 17(2):174-183
- J Clin Invest, 2018 128(7):2877-2893
- J Exp Med, 2018 215(10):2600-2616
- Hepatology, 2018 68(5):1922-1936
- Cancer Lett, 2018 415:73-85
- Int J Biol Sci, 2018 14(9):1054-1066
- Cell Death Dis, 2018 9(7):728
- Food Chem, 2018 240:534-543
- Oncogene, 2018 37(5):589-600
- Stem Cell Res Ther, 2018 9(1):65
- Front Immunol, 2018 9:647
- Br J Pharmacol, 2018 175(8):1329-1343
- Thromb Haemost, 2018 118(7):1215-1229
- Life Sci, 2018 209:111-121
- Cancer Immunol Immunother, 2018 67(2):271-283
- Mol Cancer Ther, 2018 17(6):1291-1302
- J Cell Physiol, 2018 234(1):454-463
- J Cell Physiol, 2018 233(3):2409-2419
- Eur J Immunol, 2018 48(11):1838-1850
- Front Cell Neurosci, 2018 12:230
- Virulence, 2018 9(1):1403-1421
- Aging (Albany NY), 2018 10(1):56-71
- Cell Signal, 2018 43:85-94
- FASEB J, 2018 32(9):4917-4929
- FASEB J, 2018 32(8):4096-4106
- Front Oncol, 2018 8:575
- Viruses, 2018 10(11)
- Neuropharmacology, 2018 135:34-47
- Neuropharmacology, 2018 131:223-237
- J Neurochem, 2018 144(6):780-790
- J Cell Biochem, 2018 119(12):9997-10004
- Cell Biol Int, 2018 42(1):105-111
- BMC Cancer, 2018 18(1):94
- Cytokine, 2018 111:325-333
- Cancer Biol Ther, 2018 19(11):1057-1064
- J Periodontal Res, 2018 53(3):334-344
- Bioorg Med Chem, 2018 26(22):5845-5851
- Biochem Biophys Res Commun, 2018 501(3):791-799
- Biochem Biophys Res Commun, 2018 506(1):137-144
- Exp Ther Med, 2018 16(5):4019-4029
- Tumour Biol, 2018 40(1):1010428317731369
- Cell Death Differ, 2017 24(5):866-877
- Cancer Res, 2017 77(1):100-111
- EBioMedicine, 2017 20:79-97
- Cancer Lett, 2017 389:59-69
- Int J Biol Sci, 2017 13(4):434-448
- Cell Death Dis, 2017 8(2):e2611
- Biomed Pharmacother, 2017 89:983-990
- Biomed Pharmacother, 2017 89:1037-1044
- Oxid Med Cell Longev, 2017 2017:9743280
- Front Immunol, 2017 8:1852
- Oncoimmunology, 2017 7(3):e1408745
- Mol Cell Proteomics, 2017 16(9):1694-1704
- PLoS Pathog, 2017 13(4):e1006321
- J Ethnopharmacol, 2017 200:165-173
- Int J Mol Med, 2017 40(5):1335-1346
- Int J Oncol, 2017
- Chem Biol Interact, 2017 270:1-8
- Appl Microbiol Biotechnol, 2017 101(21):7823-7835
- Sci Rep, 2017 7(1):10592
- Sci Rep, 2017 7(1):7841
- Sci Rep, 2017 7(1):14416
- Sci Rep, 2017 7:40723
- Sci Rep, 2017 7:41857
- Poult Sci, 2017 96(9):3043-3051
- Dis Model Mech, 2017 10(9):1109-1115
- BMC Cancer, 2017 17(1):432
- PLoS One, 2017 12(1):e0169665
- PLoS One, 2017 12(12):e0189920
- Toxicol In Vitro, 2017 42:86-92
- Med Sci Monit, 2017 23:1190-1199
- Biochem Biophys Res Commun, 2017 492(3):316-322
- Biochem Biophys Res Commun, 2017 487(4):820-826
- J Thorac Dis, 2017 9(11):4398-4412
- Nat Commun, 2016 7:11363
- Cancer Lett, 2016 378(2):131-41
- Oncogene, 2016 35(33):4321-34
- Antiviral Res, 2016 131:9-18
- Free Radic Biol Med, 2016 101:129-142
- Mol Oncol, 2016 10(6):775-88
- Int J Mol Med, 2016 38(3):785-93
- Oncotarget, 2016 7(27):41445-41459
- Oncotarget, 2016 7(30):48547-48561
- J Mol Cell Cardiol, 2016 101:1-10
- Biochim Biophys Acta, 2016 1859(4):564-71
- J Mol Med (Berl), 2016 94(2):195-206
- J Immunol, 2016 196(3):1284-92
- Mol Cell Endocrinol, 2016 419:235-43
- PLoS One, 2016 11(9):e0161975
- Exp Eye Res, 2016 145:456-467
- Bioorg Med Chem Lett, 2016 26(2):440-444
- J Interferon Cytokine Res, 2016 36(9):552-62
- Hua Xi Kou Qiang Yi Xue Za Zhi, 2016 34(5):454-458
- Mutat Res, 2016 789:1-8
- Oncotarget, 2015
- Oncotarget, 2015 6(10):8244-54
- Oncotarget, 2015 6(37):39839-54
- J Cell Mol Med, 2015 10.1111/jcmm.12495
- Int J Oncol, 2015 47(2):701-9
- Arthritis Res Ther, 2015 10.1186/s13075-015-0605-6
- Arthritis Res Ther, 2015 17:91
- Mediators Inflamm, 2015 2015:720457
- Mol Immunol, 2015 68(2 Pt C):671-83
- Prostate, 2015 10.1002/pros.22945
- Tumour Biol, 2015 10.1007/s13277-015-4172-x
- Tumour Biol, 2015 36(12):9499-510
- Cardiovasc Diabetol, 2014 13:41
- Int J Cancer, 2014 135(2):282-94
- J Biol Chem, 2014 289(30):21028-21039
- Oncol Rep, 2014 32(6):2777-88
- Tumour Biol, 2014 35(10):10267-73
化学信息&溶解度
分子量 | 207.25 |
分子式 | C10H9NO2S |
CAS号 | 19542-67-7 |
Smiles | CC1=CC=C(C=C1)S(=O)(=O)C=CC#N |
储存条件(自收到货起) | |
建议分装储备液,避免反复冻融! |
|
体外溶解度 | 批次: |
DMSO : 41 mg/mL ( 197.82 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 10 mg/mL Water : Insoluble DMSO : 41 mg/mL ( 197.82 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 10 mg/mL Water : Insoluble DMSO : 41 mg/mL ( 197.82 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 3 mg/mL Water : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
10%DMSO
40%PEG300
5%Tween80
45%ddH2O
浓度:4mg/ml
(19.30mM)
操作示例:以 1 mL 工作液为例,取100μL40mg/ml的澄清DMSO储备液加到400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入450μL ddH2O定容至 1 mL。工作液请现配现用!
|
|
5%DMSO
Corn oil
浓度:8mg/ml
(38.60mM)
操作示例:以 1 mL 工作液为例,取50μL160mg/ml的澄清DMSO储备液加到950μL玉米油中,混合均匀。工作液请现配现用!
|
|
5%DMSO
40%PEG300
5%Tween80
50%ddH2O
浓度:2mg/ml
(9.65mM)
操作示例:以 1 mL 工作液为例,取50μL40mg/ml的澄清DMSO储备液加到400μLPEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入500μLddH2O定容至1mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。